Evidence map›Paper›PMID 36605748›Full record

ReviewChemical science2022

Polyoxometalate-peptide hybrid materials: from structure-property relationships to applications.

Héctor Soria-Carrera, Elena Atrián-Blasco, Rafael Martín-Rapún, Scott G Mitchell

Open access · diamondAbstract readReview
In one paragraph

Review in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. RSC advances · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Photoelectrochemical biosensor based on SiWFrontiers in bioengineering and biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Héctor Soria-CarreraInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza c/ Pedro Cerbuna 12 50009 Zaragoza Spain rmartin@unizar.es scott.mitchell@csic.es.ORCID https://orcid.org/0000-0002-5823-0314
Elena Atrián-BlascoInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza c/ Pedro Cerbuna 12 50009 Zaragoza Spain rmartin@unizar.es scott.mitchell@csic.es.ORCID https://orcid.org/0000-0002-3830-7847
Rafael Martín-RapúnInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza c/ Pedro Cerbuna 12 50009 Zaragoza Spain rmartin@unizar.es scott.mitchell@csic.es.ORCID https://orcid.org/0000-0003-0702-8260
Scott G MitchellInstituto de Nanociencia y Materiales de Aragón (INMA), CSIC-Universidad de Zaragoza c/ Pedro Cerbuna 12 50009 Zaragoza Spain rmartin@unizar.es scott.mitchell@csic.es.ORCID https://orcid.org/0000-0003-4848-414X
Universidad de Zaragoza · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organo-functionalisation of polyoxometalates (POMs) represents an effective approach to obtain diverse arrays of functional structures and materials, where the introduction of organic moieties into the POM molecules can dramatically change their surface chemistry, charge, polarity, and redox properties. The synergistic combination of POMs and peptides, which perform a myriad of essential roles within cellular biochemistry, including protection and transport in living organisms, leads to functional hybrid materials with unique properties. In this Perspective article, we present the principal synthetic routes to prepare and characterise POM-peptide hybrids, together with a comprehensive description of how their properties - such as redox chemistry, stereochemistry and supramolecular self-assembly - give rise to materials with relevant catalytic, adhesive, and biomedical applications. By presenting the state-of-the-art of the POM-peptide field, we show specifically how emerging chemical approaches can be harnessed to develop tailored POM-peptide materials with synergistic properties for applications in a variety of disciplines.

Identifiers

PMID36605748
PMCPMC9769095
OpenAlexW4313214652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.